Clinical prediction models for treatment outcomes in newly diagnosed epilepsy: A systematic review.

Ratcliffe, Corey, Pradeep, Vishnav, Marson, Anthony ORCID: 0000-0002-6861-8806, Keller, Simon S ORCID: 0000-0001-5247-9795 and Bonnett, Laura J ORCID: 0000-0002-6981-9212 (2024) Clinical prediction models for treatment outcomes in newly diagnosed epilepsy: A systematic review. Epilepsia, 65 (7). pp. 1811-1846. ISSN 0013-9580, 1528-1167

Text ratcliffe_et_al._2024_clinical-prediction-models-for-treatment-outcomes.pdf - Open Access published version Download (5MB) | Preview

Abstract

Up to 35% of individuals diagnosed with epilepsy continue to have seizures despite treatment, commonly referred to as drug-resistant epilepsy. Uncontrolled seizures can directly, or indirectly, negatively impact an individual's quality of life. To inform clinical management and life decisions, it is important to be able to predict the likelihood of seizure control. Those likely to achieve seizure control will be able to return sooner to their usual work and leisure activities and require less follow-up, whereas those with a poor prognosis will need more frequent clinical attendance and earlier consideration of epilepsy surgery. This is a systematic review aimed at identifying demographic, clinical, physiological (e.g., electroencephalographic), and imaging (e.g., magnetic resonance imaging) factors that may be predictive of treatment outcomes in patients with newly diagnosed epilepsy (NDE). MEDLINE and Embase were searched for prediction models of treatment outcomes in patients with NDE. Study characteristics were extracted and subjected to assessment of risk of bias (and applicability concerns) using the PROBAST (Prediction Model Risk of Bias Assessment Tool) tool. Baseline variables associated with treatment outcomes are reported as prognostic factors. After screening, 48 models were identified in 32 studies, which generally scored low for concerns of applicability, but universally scored high for susceptibility to bias. Outcomes reported fit broadly into four categories: drug resistance, short-term treatment response, seizure remission, and mortality. Prognostic factors were also heterogenous, but the predictors that were commonly significantly associated with outcomes were those related to seizure characteristics/types, epilepsy history, and age at onset. Antiseizure medication response was often included as a baseline variable, potentially obscuring other factor relationships at baseline. Currently, outcome prediction models for NDE demonstrate a high risk of bias. Model development could be improved with a stronger adherence to recommended TRIPOD (Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis) practices. Furthermore, we outline actionable changes to common practices that are intended to improve the overall quality of prediction model development in NDE.

Item Type:	Article
Uncontrolled Keywords:	intractability, newly diagnosed epilepsy, outcomes, prognosis, seizures, treatment
Depositing User:	Symplectic Admin
Date Deposited:	02 Aug 2024 08:01
Last Modified:	16 Jun 2026 17:02
DOI:	10.1111/epi.17994
Related Websites:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3183276
Disclaimer:	The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate.